{"id":4610,"date":"2024-01-13T16:26:10","date_gmt":"2024-01-13T15:26:10","guid":{"rendered":"http:\/\/genekam.mosquitobornediseases.com\/?page_id=4610"},"modified":"2024-02-08T00:32:04","modified_gmt":"2024-02-07T23:32:04","slug":"antiviral-solutions-2","status":"publish","type":"page","link":"https:\/\/genekam.de\/index.php\/antiviral-solutions-2\/","title":{"rendered":"Antiviral Solutions"},"content":{"rendered":"\t\t<div data-elementor-type=\"wp-page\" data-elementor-id=\"4610\" class=\"elementor elementor-4610\">\n\t\t\t\t\t\t\t<div class=\"elementor-element elementor-element-c394f78 e-flex e-con-boxed e-con e-parent\" data-id=\"c394f78\" data-element_type=\"container\" data-settings=\"{&quot;content_width&quot;:&quot;boxed&quot;}\" data-core-v316-plus=\"true\">\n\t\t\t\t\t<div class=\"e-con-inner\">\n\t\t\t\t<div class=\"elementor-element elementor-element-8dd31a5 elementor-widget elementor-widget-heading\" data-id=\"8dd31a5\" data-element_type=\"widget\" data-widget_type=\"heading.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t<style>\/*! elementor - v3.16.0 - 20-09-2023 *\/\n.elementor-heading-title{padding:0;margin:0;line-height:1}.elementor-widget-heading .elementor-heading-title[class*=elementor-size-]>a{color:inherit;font-size:inherit;line-height:inherit}.elementor-widget-heading .elementor-heading-title.elementor-size-small{font-size:15px}.elementor-widget-heading .elementor-heading-title.elementor-size-medium{font-size:19px}.elementor-widget-heading .elementor-heading-title.elementor-size-large{font-size:29px}.elementor-widget-heading .elementor-heading-title.elementor-size-xl{font-size:39px}.elementor-widget-heading .elementor-heading-title.elementor-size-xxl{font-size:59px}<\/style><h2 class=\"elementor-heading-title elementor-size-default\">Antiviral Solutions<\/h2>\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<div class=\"elementor-element elementor-element-a6370bb elementor-widget elementor-widget-text-editor\" data-id=\"a6370bb\" data-element_type=\"widget\" data-widget_type=\"text-editor.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t<style>\/*! elementor - v3.16.0 - 20-09-2023 *\/\n.elementor-widget-text-editor.elementor-drop-cap-view-stacked .elementor-drop-cap{background-color:#69727d;color:#fff}.elementor-widget-text-editor.elementor-drop-cap-view-framed .elementor-drop-cap{color:#69727d;border:3px solid;background-color:transparent}.elementor-widget-text-editor:not(.elementor-drop-cap-view-default) .elementor-drop-cap{margin-top:8px}.elementor-widget-text-editor:not(.elementor-drop-cap-view-default) .elementor-drop-cap-letter{width:1em;height:1em}.elementor-widget-text-editor .elementor-drop-cap{float:left;text-align:center;line-height:1;font-size:50px}.elementor-widget-text-editor .elementor-drop-cap-letter{display:inline-block}<\/style>\t\t\t\t<p>Genekam Biotechnology AG has developed a number of solutions and molecules, which can be used to inhibit the Ebola infections in order to create new therapies. These molecules can be sourced from us and laboratories around the world can conduct the research studies e.g. preclinical and clinical to demostrate that these molecules can inhibit the Ebola viruses. Not only this, we are trying to develop more molecules to inhibit the Middle east Respiratory syndrome viruses infections (SARS virus), dengue viruses, Influenza viruses as well as animal viruses like Foot and mouth disease etc.<\/p><p>Genekam has developed two different systems to create the molecules, which have potential to be used as therapies one day:<\/p>\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t<div class=\"elementor-element elementor-element-f82beb1 elementor-hidden-desktop elementor-hidden-tablet elementor-hidden-mobile e-flex e-con-boxed e-con e-parent\" data-id=\"f82beb1\" data-element_type=\"container\" data-settings=\"{&quot;content_width&quot;:&quot;boxed&quot;}\" data-core-v316-plus=\"true\">\n\t\t\t\t\t<div class=\"e-con-inner\">\n\t\t<div class=\"elementor-element elementor-element-0d2c48a e-con-full e-flex e-con e-child\" data-id=\"0d2c48a\" data-element_type=\"container\" data-settings=\"{&quot;content_width&quot;:&quot;full&quot;}\">\n\t\t\t\t<div class=\"elementor-element elementor-element-5a764a7 elementor-widget elementor-widget-image\" data-id=\"5a764a7\" data-element_type=\"widget\" data-widget_type=\"image.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t<style>\/*! elementor - v3.16.0 - 20-09-2023 *\/\n.elementor-widget-image{text-align:center}.elementor-widget-image a{display:inline-block}.elementor-widget-image a img[src$=\".svg\"]{width:48px}.elementor-widget-image img{vertical-align:middle;display:inline-block}<\/style>\t\t\t\t\t\t\t\t\t\t\t\t<img loading=\"lazy\" decoding=\"async\" width=\"1024\" height=\"536\" src=\"https:\/\/genekam.de\/wp-content\/uploads\/2024\/01\/Ebola-options-1024x536.jpg\" class=\"attachment-large size-large wp-image-4624\" alt=\"\" srcset=\"https:\/\/genekam.de\/wp-content\/uploads\/2024\/01\/Ebola-options-1024x536.jpg 1024w, https:\/\/genekam.de\/wp-content\/uploads\/2024\/01\/Ebola-options-300x157.jpg 300w, https:\/\/genekam.de\/wp-content\/uploads\/2024\/01\/Ebola-options-768x402.jpg 768w, https:\/\/genekam.de\/wp-content\/uploads\/2024\/01\/Ebola-options.jpg 1200w\" sizes=\"auto, (max-width: 1024px) 100vw, 1024px\" \/>\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t<div class=\"elementor-element elementor-element-d7718c4 e-con-full e-flex e-con e-child\" data-id=\"d7718c4\" data-element_type=\"container\" data-settings=\"{&quot;content_width&quot;:&quot;full&quot;}\">\n\t\t\t\t<div class=\"elementor-element elementor-element-38f701f elementor-widget elementor-widget-text-editor\" data-id=\"38f701f\" data-element_type=\"widget\" data-widget_type=\"text-editor.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t\t\t<p>These molecules offer the new chances to many laboratories around the world to conduct the research in the field of therapies. Much of research work can be conducted and published as Master or Ph.D. thesis or reseach paper. These molecules are being offered to any laboratory around the world to conduct world class research in the field of therapeutic or inhibiting the viral pathogens. The above said molecules can be used to inhibit the viruses in human and animals i.e. if they have potential to be used for human and veterinary medicine one day.<\/p>\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t<div class=\"elementor-element elementor-element-138f8cb elementor-hidden-desktop elementor-hidden-tablet elementor-hidden-mobile e-flex e-con-boxed e-con e-parent\" data-id=\"138f8cb\" data-element_type=\"container\" data-settings=\"{&quot;content_width&quot;:&quot;boxed&quot;}\" data-core-v316-plus=\"true\">\n\t\t\t\t\t<div class=\"e-con-inner\">\n\t\t\t\t<div class=\"elementor-element elementor-element-f008697 elementor-widget elementor-widget-eael-advanced-data-table\" data-id=\"f008697\" data-element_type=\"widget\" data-widget_type=\"eael-advanced-data-table.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t<div class=\"ea-advanced-data-table-wrap\" data-id=\"f008697\"><div class=\"ea-advanced-data-table-wrap-inner\">\n                <table class=\"ea-advanced-data-table ea-advanced-data-table-static ea-advanced-data-table-f008697 ea-advanced-data-table-sortable ea-advanced-data-table-paginated\" data-id=\"f008697\" data-items-per-page=\"100\"><tbody><tr><td>2.1 Genekam-T-001 A molecule against Ebola virus<\/td><td>10 reactions\t<\/td><td>call<\/td><\/tr><tr><td>2.2 Genekam-T-002 A molecule against Ebola virus<\/td><td>10 reactions<\/td><td>call<\/td><\/tr><tr><td>2.3 Genekam-T-003 A molecule against Ebola virus<\/td><td>10 reactions<\/td><td>call<\/td><\/tr><tr><td>2.4 Genekam-T-004 A molecule against Ebola virus<\/td><td>10 reactions<\/td><td>call<\/td><\/tr><tr><td>2.5 Genekam-T-005 A molecule against Ebola virus<\/td><td>10 reactions<\/td><td>call<\/td><\/tr><tr><td>2.6 Genekam-T-006 A molecule against Ebola virus<\/td><td>10 reactions<\/td><td>call<\/td><\/tr><tr><td>2.7 Genekam-T-007 A molecule against Ebola virus<\/td><td>10 reactions<\/td><td>call<\/td><\/tr><tr><td>2.8 Genekam-T-008 A molecule against MERS virus<\/td><td>10 reactions<\/td><td>call (available within 2 weeks)<\/td><\/tr><tr><td>2.9 Genekam-T-009 A molecule against MERS virus<\/td><td>10 reactions<\/td><td>call (available within 2 weeks)<\/td><\/tr><tr><td>2.10 Genekam-T-010 A molecule against MERS virus<\/td><td>10 reactions<\/td><td>call (available within 2-3 weeks)<\/td><\/tr><tr><td>2.11 Genekam-T-011 A molecule against Foot and mouth disease (FMD)<\/td><td>10 reactions<\/td><td>call (available 4-8 weeks or later)<\/td><\/tr><\/tbody><\/table>\n            <\/div><div class=\"ea-advanced-data-table-pagination ea-advanced-data-table-pagination-button clearfix\"><\/div><\/div>\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<div class=\"elementor-element elementor-element-7087126 elementor-widget elementor-widget-text-editor\" data-id=\"7087126\" data-element_type=\"widget\" data-widget_type=\"text-editor.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t\t\t<p>Please work with us for these molecules. If there will be successful with the research of such molecules, applications of these molecules may change the ways to generate the new therapies in future.<\/p>\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t<div class=\"elementor-element elementor-element-6fd89bd e-flex e-con-boxed e-con e-parent\" data-id=\"6fd89bd\" data-element_type=\"container\" data-settings=\"{&quot;content_width&quot;:&quot;boxed&quot;}\" data-core-v316-plus=\"true\">\n\t\t\t\t\t<div class=\"e-con-inner\">\n\t\t\t\t<div class=\"elementor-element elementor-element-7d14f79 elementor-widget elementor-widget-heading\" data-id=\"7d14f79\" data-element_type=\"widget\" data-widget_type=\"heading.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t<h2 class=\"elementor-heading-title elementor-size-default\">Liste of therapeutic Molecules (Genekam):  <\/h2>\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<div class=\"elementor-element elementor-element-19599c4 elementor-widget elementor-widget-eael-advanced-data-table\" data-id=\"19599c4\" data-element_type=\"widget\" data-widget_type=\"eael-advanced-data-table.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t<div class=\"ea-advanced-data-table-wrap\" data-id=\"19599c4\"><div class=\"ea-advanced-data-table-wrap-inner\">\n                <table class=\"ea-advanced-data-table ea-advanced-data-table-static ea-advanced-data-table-19599c4 ea-advanced-data-table-sortable ea-advanced-data-table-paginated\" data-id=\"19599c4\" data-items-per-page=\"100\"><tbody><tr><td><p><br><\/p><\/td><td><p><strong>Therapeutic Molecules&nbsp;&nbsp;<\/strong><\/p><\/td><td><p><strong>Stage 1 (Development)<\/strong><\/p><\/td><td><p><strong>Stage 2 (In vitro studies)<\/strong><\/p><\/td><\/tr><tr><td><p>TM1<\/p><\/td><td><p>Activin A receptor II&nbsp;<\/p><\/td><td><\/td><td><\/td><\/tr><tr><td><p>TM2<\/p><\/td><td><p>Dengue Virus 2 -Version 1<\/p><\/td><td><p>passed<\/p><\/td><td><\/td><\/tr><tr><td><p>TM3<\/p><\/td><td><p>Dengue Virus 2 -Version 2<\/p><\/td><td><p>passed<\/p><\/td><td><\/td><\/tr><tr><td><p>TM4<\/p><\/td><td><p>Dengue Virus 2 -Version 3&nbsp;<\/p><\/td><td><p>passed<\/p><\/td><td><\/td><\/tr><tr><td><p>TM5<\/p><\/td><td><p>Dengue Virus 2 -Version 4&nbsp;<\/p><\/td><td><p>passed<\/p><\/td><td><\/td><\/tr><tr><td><p>TM6<\/p><\/td><td><p>Ebolavirus \u2013 Version 1<\/p><\/td><td><p>passed<\/p><\/td><td><\/td><\/tr><tr><td><p>TM7<\/p><\/td><td><p>Ebolavirus -Version 2<\/p><\/td><td><p>passed<\/p><\/td><td><\/td><\/tr><tr><td><p>TM8<\/p><\/td><td><p>Epstein Barr Virus&nbsp;<\/p><\/td><td><p>passed<\/p><\/td><td><\/td><\/tr><tr><td><p>TM9<\/p><\/td><td><p>H5N1 Neuraminidase<\/p><\/td><td><p>passed<\/p><\/td><td><\/td><\/tr><tr><td><p>TM10<\/p><\/td><td><p>H5N1 Matrix<\/p><\/td><td><p>passed<\/p><\/td><td><\/td><\/tr><tr><td><p>TM11<\/p><\/td><td><p>H5N1 Hemagglutinin<\/p><\/td><td><p>passed<\/p><\/td><td><\/td><\/tr><tr><td><p>TM12<\/p><\/td><td><p>Human Polyomavirus -Version 1<\/p><\/td><td><p>passed<\/p><\/td><td><\/td><\/tr><tr><td><p>TM13<\/p><\/td><td><p>Human Polyomavirus -Version 2<\/p><\/td><td><p>passed<\/p><\/td><td><\/td><\/tr><tr><td><p>TM14<\/p><\/td><td><p>Human Papillomavirus 16<\/p><\/td><td><p>passed<\/p><\/td><td><\/td><\/tr><tr><td><p>TM15<\/p><\/td><td><p>Human Papillomavirus 5<\/p><\/td><td><p>passed<\/p><\/td><td><\/td><\/tr><tr><td><p>TM16<\/p><\/td><td><p>Human CD38 -Version 1<\/p><\/td><td><p>passed<\/p><\/td><td><\/td><\/tr><tr><td><p>TM17<\/p><\/td><td><p>Human CD38 -Version 2<\/p><\/td><td><p>passed<\/p><\/td><td><\/td><\/tr><tr><td><p>TM18<\/p><\/td><td><p>Human CD27&nbsp;<\/p><\/td><td><p>passed<\/p><\/td><td><\/td><\/tr><tr><td><p>TM19<\/p><\/td><td><p>Human CD19<\/p><\/td><td><p>passed<\/p><\/td><td><\/td><\/tr><tr><td><p>TM20<\/p><\/td><td><p>Japanese Encephalitis Virus<\/p><\/td><td><p>passed<\/p><\/td><td><\/td><\/tr><tr><td><p>TM21<\/p><\/td><td><p>Middle East Respiratory Syndrom (MERS<\/p><\/td><td><p>passed<\/p><\/td><td><\/td><\/tr><tr><td><p>Z103<\/p><\/td><td><p>Porphyromonas gingivalis<\/p><\/td><td><p>passed<\/p><\/td><td><\/td><\/tr><tr><td><p>TM22<\/p><\/td><td><p>Rabies (Lyssavirus rabies)<\/p><\/td><td><p>passed<\/p><\/td><td><\/td><\/tr><tr><td><p>TM23<\/p><\/td><td><p>Rift Valley Fever Virus<\/p><\/td><td><p>passed<\/p><\/td><td><\/td><\/tr><tr><td><p>TM24<\/p><\/td><td><p>TNF alfa<\/p><\/td><td><p>passed<\/p><\/td><td><\/td><\/tr><tr><td><p>TM21<\/p><\/td><td><p>Wuhan Corona<\/p><\/td><td><p>passed<\/p><\/td><td><\/td><\/tr><tr><td><p>Z101, Z102<\/p><\/td><td><p>Zika Virus<\/p><\/td><td><p>passed<\/p><\/td><td><p>passed<\/p><\/td><\/tr><\/tbody><\/table>\n            <\/div><div class=\"ea-advanced-data-table-pagination ea-advanced-data-table-pagination-button clearfix\"><\/div><\/div>\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t\t\t<\/div>\n\t\t","protected":false},"excerpt":{"rendered":"Antiviral Solutions Genekam Biotechnology AG has developed a number of solutions and molecules, which can be used to inhibit the Ebola infections in order to create new therapies. These molecules can be sourced from us and laboratories around the world can conduct the research studies e.g. preclinical and clinical to demostrate that these molecules can ","protected":false},"author":1,"featured_media":0,"parent":0,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"","meta":{"inline_featured_image":false,"footnotes":""},"class_list":["post-4610","page","type-page","status-publish","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v22.2 - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>Antiviral Solutions - Genekam Biotechnology AG<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/genekam.de\/index.php\/antiviral-solutions-2\/\" \/>\n<meta property=\"og:locale\" content=\"de_DE\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Antiviral Solutions - Genekam Biotechnology AG\" \/>\n<meta property=\"og:description\" content=\"Antiviral Solutions Genekam Biotechnology AG has developed a number of solutions and molecules, which can be used to inhibit the Ebola infections in order to create new therapies. These molecules can be sourced from us and laboratories around the world can conduct the research studies e.g. preclinical and clinical to demostrate that these molecules can\" \/>\n<meta property=\"og:url\" content=\"https:\/\/genekam.de\/index.php\/antiviral-solutions-2\/\" \/>\n<meta property=\"og:site_name\" content=\"Genekam Biotechnology AG\" \/>\n<meta property=\"article:modified_time\" content=\"2024-02-07T23:32:04+00:00\" \/>\n<meta property=\"og:image\" content=\"http:\/\/genekam.de\/wp-content\/uploads\/2024\/01\/Ebola-options-1024x536.jpg\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Gesch\u00e4tzte Lesezeit\" \/>\n\t<meta name=\"twitter:data1\" content=\"2\u00a0Minuten\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/genekam.de\/index.php\/antiviral-solutions-2\/\",\"url\":\"https:\/\/genekam.de\/index.php\/antiviral-solutions-2\/\",\"name\":\"Antiviral Solutions - Genekam Biotechnology AG\",\"isPartOf\":{\"@id\":\"https:\/\/genekam.de\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/genekam.de\/index.php\/antiviral-solutions-2\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/genekam.de\/index.php\/antiviral-solutions-2\/#primaryimage\"},\"thumbnailUrl\":\"http:\/\/genekam.de\/wp-content\/uploads\/2024\/01\/Ebola-options-1024x536.jpg\",\"datePublished\":\"2024-01-13T15:26:10+00:00\",\"dateModified\":\"2024-02-07T23:32:04+00:00\",\"breadcrumb\":{\"@id\":\"https:\/\/genekam.de\/index.php\/antiviral-solutions-2\/#breadcrumb\"},\"inLanguage\":\"de\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/genekam.de\/index.php\/antiviral-solutions-2\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"de\",\"@id\":\"https:\/\/genekam.de\/index.php\/antiviral-solutions-2\/#primaryimage\",\"url\":\"http:\/\/genekam.de\/wp-content\/uploads\/2024\/01\/Ebola-options-1024x536.jpg\",\"contentUrl\":\"http:\/\/genekam.de\/wp-content\/uploads\/2024\/01\/Ebola-options-1024x536.jpg\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/genekam.de\/index.php\/antiviral-solutions-2\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Startseite\",\"item\":\"https:\/\/genekam.de\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Antiviral Solutions\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/genekam.de\/#website\",\"url\":\"https:\/\/genekam.de\/\",\"name\":\"Genekam Biotechnology AG\",\"description\":\"\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/genekam.de\/?s={search_term_string}\"},\"query-input\":\"required name=search_term_string\"}],\"inLanguage\":\"de\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Antiviral Solutions - Genekam Biotechnology AG","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/genekam.de\/index.php\/antiviral-solutions-2\/","og_locale":"de_DE","og_type":"article","og_title":"Antiviral Solutions - Genekam Biotechnology AG","og_description":"Antiviral Solutions Genekam Biotechnology AG has developed a number of solutions and molecules, which can be used to inhibit the Ebola infections in order to create new therapies. These molecules can be sourced from us and laboratories around the world can conduct the research studies e.g. preclinical and clinical to demostrate that these molecules can","og_url":"https:\/\/genekam.de\/index.php\/antiviral-solutions-2\/","og_site_name":"Genekam Biotechnology AG","article_modified_time":"2024-02-07T23:32:04+00:00","og_image":[{"url":"http:\/\/genekam.de\/wp-content\/uploads\/2024\/01\/Ebola-options-1024x536.jpg"}],"twitter_card":"summary_large_image","twitter_misc":{"Gesch\u00e4tzte Lesezeit":"2\u00a0Minuten"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/genekam.de\/index.php\/antiviral-solutions-2\/","url":"https:\/\/genekam.de\/index.php\/antiviral-solutions-2\/","name":"Antiviral Solutions - Genekam Biotechnology AG","isPartOf":{"@id":"https:\/\/genekam.de\/#website"},"primaryImageOfPage":{"@id":"https:\/\/genekam.de\/index.php\/antiviral-solutions-2\/#primaryimage"},"image":{"@id":"https:\/\/genekam.de\/index.php\/antiviral-solutions-2\/#primaryimage"},"thumbnailUrl":"http:\/\/genekam.de\/wp-content\/uploads\/2024\/01\/Ebola-options-1024x536.jpg","datePublished":"2024-01-13T15:26:10+00:00","dateModified":"2024-02-07T23:32:04+00:00","breadcrumb":{"@id":"https:\/\/genekam.de\/index.php\/antiviral-solutions-2\/#breadcrumb"},"inLanguage":"de","potentialAction":[{"@type":"ReadAction","target":["https:\/\/genekam.de\/index.php\/antiviral-solutions-2\/"]}]},{"@type":"ImageObject","inLanguage":"de","@id":"https:\/\/genekam.de\/index.php\/antiviral-solutions-2\/#primaryimage","url":"http:\/\/genekam.de\/wp-content\/uploads\/2024\/01\/Ebola-options-1024x536.jpg","contentUrl":"http:\/\/genekam.de\/wp-content\/uploads\/2024\/01\/Ebola-options-1024x536.jpg"},{"@type":"BreadcrumbList","@id":"https:\/\/genekam.de\/index.php\/antiviral-solutions-2\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Startseite","item":"https:\/\/genekam.de\/"},{"@type":"ListItem","position":2,"name":"Antiviral Solutions"}]},{"@type":"WebSite","@id":"https:\/\/genekam.de\/#website","url":"https:\/\/genekam.de\/","name":"Genekam Biotechnology AG","description":"","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/genekam.de\/?s={search_term_string}"},"query-input":"required name=search_term_string"}],"inLanguage":"de"}]}},"_links":{"self":[{"href":"https:\/\/genekam.de\/index.php\/wp-json\/wp\/v2\/pages\/4610","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/genekam.de\/index.php\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/genekam.de\/index.php\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/genekam.de\/index.php\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/genekam.de\/index.php\/wp-json\/wp\/v2\/comments?post=4610"}],"version-history":[{"count":7,"href":"https:\/\/genekam.de\/index.php\/wp-json\/wp\/v2\/pages\/4610\/revisions"}],"predecessor-version":[{"id":5292,"href":"https:\/\/genekam.de\/index.php\/wp-json\/wp\/v2\/pages\/4610\/revisions\/5292"}],"wp:attachment":[{"href":"https:\/\/genekam.de\/index.php\/wp-json\/wp\/v2\/media?parent=4610"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}